LIGAND PHARM Backtesting

LGNZZ -- USA Stock  

USD 0.12  0.01  8.00%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of LIGAND PHARM INC and determine expected loss or profit from investing in LIGAND PHARM over given investment horizon. Please see also LIGAND PHARM Hype Analysis, LIGAND PHARM Correlation, LIGAND PHARM Valuation, LIGAND PHARM Volatility as well as analyze LIGAND PHARM Alpha and Beta and LIGAND PHARM Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

LIGAND PHARM 'What if' Analysis

August 21, 2018
0.00
No Change 0.00  0.0%
In 30 days
September 20, 2018
0.00
If you would invest  0.00  in LIGAND PHARM on August 21, 2018 and sell it all today you would earn a total of 0.00 from holding LIGAND PHARM INC or generate 0.0% return on investment in LIGAND PHARM over 30 days. LIGAND PHARM is related to or competes with Alamos Gold, Vedanta, Alphabet, Hero MotoCorp, CHINA LIFE, BERKSHIRE HATHAWAY, and Chesapeake Energy.

LIGAND PHARM Upside/Downside Indicators

Information Ratio0.1831
Maximum Drawdown26.79
Value At Risk8.00
Potential Upside14.29
  

LIGAND PHARM Market Premium Indicators

Risk Adjusted Performance0.0844
Jensen Alpha1.74
Total Risk Alpha0.79
Treynor Ratio0.1969

LIGAND PHARM INC Backtested Returns

LIGAND PHARM is abnormally risky given 1 month investment horizon. LIGAND PHARM INC has Sharpe Ratio of 0.189 which conveys that LIGAND PHARM INC had 0.189% of return per unit of risk over the last 1 month. Our philosophy towards estimating volatility of a stock is to use LIGAND PHARM INC market data together with company specific technical indicators. We found twenty-one different technical indicators which can help you to evaluate if expected returns of 3.289% are justified by taking the suggested risk. Use LIGAND PHARM INC Mean Deviation of 7.84 and Risk Adjusted Performance of 0.0844 to evaluate company specific risk that cannot be diversified away. LIGAND PHARM holds performance score of 12 on a scale of zero to a hundred. The company secures Beta (Market Risk) of 16.6549 which conveys that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, LIGAND PHARM will likely underperform.. Although it is essential to pay attention to LIGAND PHARM INC price patterns, it is also good to be reasonable about what you can actually do with equity historical price patterns. Macroaxis philosophy towards estimating future performance of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if LIGAND PHARM expected return of 3.289 will be sustainable into the future, we have found twenty-one different technical indicators which can help you to check if the expected returns are sustainable. Use LIGAND PHARM INC Standard Deviation, Value At Risk, Kurtosis, as well as the relationship between Jensen Alpha and Semi Variance to analyze future returns on LIGAND PHARM INC.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.15) 

Insignificant reverse predictability

LIGAND PHARM INC has insignificant reverse predictability. Overlapping area represents the amount of predictability between LIGAND PHARM time series from August 21, 2018 to September 5, 2018 and September 5, 2018 to September 20, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LIGAND PHARM INC price movement. The serial correlation of -0.15 indicates that less than 15.0% of current LIGAND PHARM price fluctuation can be explain by its past prices. Given that LIGAND PHARM INC has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of LIGAND PHARM for similar time interval.
Correlation Coefficient-0.15
Spearman Rank Test0.81
Residual Average0.0
Price Variance0.0

LIGAND PHARM INC lagged returns against current returns

 Current and Lagged Values 
      Timeline 

LIGAND PHARM regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

LIGAND PHARM Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - LGNZZ

LIGAND PHARM INC Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in LIGAND PHARM INC. What is your trading attitude regarding investing in LIGAND PHARM INC? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also LIGAND PHARM Hype Analysis, LIGAND PHARM Correlation, LIGAND PHARM Valuation, LIGAND PHARM Volatility as well as analyze LIGAND PHARM Alpha and Beta and LIGAND PHARM Performance. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Search macroaxis.com